Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.0550 (-4.45%) ($8.0550 - $8.0550) on Fri. Mar. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.02% (three month average) | RSI | 59 | Latest Price | $8.0550(-4.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(69%) ARKK(65%) IWO(64%) IBB(62%) | Factors Impacting CGEN price | CGEN will decline at least -2.51% in a week (0% probabilities). VIXM(-45%) VXX(-38%) UUP(-19%) IGOV(-13%) TLT(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.51% (StdDev 5.02%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.59(-144.57%) | Resistance Level | $8.74 | 5 Day Moving Average | $8.44(-4.56%) | 10 Day Moving Average | $8.72(-7.63%) | 20 Day Moving Average | $8.74(-7.84%) | To recent high | -41.7% | To recent low | 5.7% | Market Cap | $666m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |